Linc00673 (ERRLR01) is a Prognostic Indicator of Overall Survival in Breast Cancer
Overview
Affiliations
LncRNAs are novel noncoding RNAs involved in the epigenetic regulation of gene expression by recruiting ribonucleoprotein complexes to specific genomic loci to initiate histone methylation and/or other chromatin modifications. LncRNAs themselves function as tumor suppressors or oncogenes, depending on the gene regulatory networks they govern. We identified lnc00673 (ERRLR01) as a marker of overall survival (OS) in breast cancer patients. Specifically, ERRLR01 levels were elevated in triple-negative breast cancer (TNBC) as compared with Luminal-A, Luminal-B, and HER2 breast cancer subtypes. ERRLR01 levels were also inversely correlated with breast cancer survival across all breast cancer patients. Upon stratification, OS in ERα tumors correlated with negative overall survival, while in ERα tumors, ERRLR01 correlated with positive outcomes. This suggests ERRLR01 is modulated by hormone signaling in breast cancer. Gene-network analysis revealed ERRLR01 correlated with distinct pathways including "epithelial development" and "cellular differentiation." These data suggest ERRLR01 operates as an oncogene in TNBC, as well as a biomarker in breast cancer patients.
Palcau A, Brandi R, Mehterov N, Botti C, Blandino G, Pulito C Cancers (Basel). 2023; 15(16).
PMID: 37627209 PMC: 10453179. DOI: 10.3390/cancers15164181.
Long Non Coding RNA in Triple Negative Breast Cancer: A Promising Biomarker in Tumorigenesis.
Nandagopal S, Misra S, Sankanagoudar S, Banerjee M, Sharma P, Pane S Asian Pac J Cancer Prev. 2023; 24(1):49-59.
PMID: 36708551 PMC: 10152875. DOI: 10.31557/APJCP.2023.24.1.49.
Li Y, Kong X, Wang Z, Xuan L J Cell Mol Med. 2022; 26(5):1351-1362.
PMID: 35150062 PMC: 8899180. DOI: 10.1111/jcmm.17124.
The Prognostic Value of LncRNA SLNCR1 in Cancers: A Meta-Analysis.
Cong L, Sun H, Hao M, Sun Q, Zheng Y, Cong X J Oncol. 2021; 2021:3161714.
PMID: 34733328 PMC: 8560271. DOI: 10.1155/2021/3161714.
Zhou Y, Yue Y, Fan S, Jia Q, Ding X Mol Biotechnol. 2021; 63(12):1093-1102.
PMID: 34245439 DOI: 10.1007/s12033-021-00368-x.